C. Bordes

Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus

J. Moreau, C. Goulvestre, C. Nicco, 2010, Science Translational Medicine.

Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule

V. Gouilleux-Gruart, P. Gatault, J. Halimi, 2015, mAbs.

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab

B. Vendrely, C. Combe, P. Rolland, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice

C. Combe, V. Frémeaux-Bacchi, C. Loirat, 2013, Clinical kidney journal.

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice

C. Combe, V. Frémeaux-Bacchi, C. Loirat, 2013, Clinical kidney journal.

Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus

J. Moreau, C. Goulvestre, C. Nicco, 2010, Science Translational Medicine.